Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization

Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization

Abstract Introduction Non-responders to cardiac resynchronization therapy (CRT-NR) have poor prognosis. Sacubitril/valsartan (SV) treatment improved the outcome of patients with heart failure with reduced left ventricular (LV) ejection fraction (HFrEF) in randomized trials with no data on the specif...

Full description

Bibliographic Details
Main Authors: Krisztina Mária Szabó, Anna Tóth, László Nagy, Vivien Rácz, Zsófia Pólik, Katalin Hodosi, Attila C. Nagy, Judit Barta, Attila Borbély, Zoltán Csanádi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-01-01
Series:Cardiology and Therapy
Subjects:
Heart failure with reduced ejection fraction
Cardiac resynchronization therapy
Sacubitril/valsartan
NT-pro-B-type natriuretic peptide
Online Access:https://doi.org/10.1007/s40119-023-00346-1

Internet

https://doi.org/10.1007/s40119-023-00346-1

Similar Items